10-112951574-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_001367943.1(TCF7L2):c.348C>T(p.Leu116=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00235 in 1,372,036 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0019 ( 1 hom., cov: 29)
Exomes 𝑓: 0.0024 ( 10 hom. )
Consequence
TCF7L2
NM_001367943.1 synonymous
NM_001367943.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.112
Genes affected
TCF7L2 (HGNC:11641): (transcription factor 7 like 2) This gene encodes a high mobility group (HMG) box-containing transcription factor that plays a key role in the Wnt signaling pathway. The protein has been implicated in blood glucose homeostasis. Genetic variants of this gene are associated with increased risk of type 2 diabetes. Several transcript variants encoding multiple different isoforms have been found for this gene.[provided by RefSeq, Oct 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 10-112951574-C-T is Benign according to our data. Variant chr10-112951574-C-T is described in ClinVar as [Benign]. Clinvar id is 770593.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.112 with no splicing effect.
BS2
High AC in GnomAd4 at 284 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCF7L2 | NM_001367943.1 | c.348C>T | p.Leu116= | synonymous_variant | 3/15 | ENST00000355995.9 | NP_001354872.1 | |
LOC124902502 | XR_007062291.1 | n.565+204G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCF7L2 | ENST00000355995.9 | c.348C>T | p.Leu116= | synonymous_variant | 3/15 | 1 | NM_001367943.1 | ENSP00000348274 | ||
ENST00000369391.3 | n.98+204G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.00192 AC: 285AN: 148218Hom.: 1 Cov.: 29
GnomAD3 genomes
AF:
AC:
285
AN:
148218
Hom.:
Cov.:
29
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00246 AC: 460AN: 187140Hom.: 4 AF XY: 0.00299 AC XY: 312AN XY: 104380
GnomAD3 exomes
AF:
AC:
460
AN:
187140
Hom.:
AF XY:
AC XY:
312
AN XY:
104380
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00241 AC: 2947AN: 1223710Hom.: 10 Cov.: 32 AF XY: 0.00259 AC XY: 1576AN XY: 608890
GnomAD4 exome
AF:
AC:
2947
AN:
1223710
Hom.:
Cov.:
32
AF XY:
AC XY:
1576
AN XY:
608890
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00191 AC: 284AN: 148326Hom.: 1 Cov.: 29 AF XY: 0.00178 AC XY: 129AN XY: 72298
GnomAD4 genome
AF:
AC:
284
AN:
148326
Hom.:
Cov.:
29
AF XY:
AC XY:
129
AN XY:
72298
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
7
AN:
3284
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | TCF7L2: BP4, BP7, BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at